Regulus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.24%)
Regulus Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.2%)
Regulus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.24%)
Regulus Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.2%)
Regulus Therapeutics | SC 13G:超过5%持股股东披露文件-Octagon Capital Advisors LP(6.5%),Ting Jia(6.5%)等
Regulus Therapeutics | 4:持股变动声明-董事 Collier Kathryn J
Regulus Therapeutics | 4:持股变动声明-董事 RASTETTER WILLIAM H
Regulus Therapeutics | 4:持股变动声明-董事 PAPADOPOULOS STELIOS
Regulus Therapeutics | 4:持股变动声明-董事 Witz Pascale
Regulus Therapeutics | 4:持股变动声明-董事 Rosen Hugh
Regulus Therapeutics | 4:持股变动声明-董事 Nunn Jason Raleigh
Regulus Therapeutics | 4:持股变动声明-高管 Aker Christopher Ray
Regulus Therapeutics | 4:持股变动声明-高管 CALSADA CRISPINA
Regulus Therapeutics | 4:持股变动声明-高管 Hagan Joseph P
Regulus Therapeutics | 4:持股变动声明-高管 Klassen Preston
Regulus Therapeutics | 4:持股变动声明-董事 BALTIMORE DAVID
Regulus Therapeutics | 4:持股变动声明-董事 Huang Alice Shih-hou
Regulus Therapeutics | 4:持股变动声明-董事 Collier Kathryn J
Regulus Therapeutics | 4:持股变动声明-董事 Collier Kathryn J
Regulus Therapeutics | 4:持股变动声明-董事 Nunn Jason Raleigh
暂无数据
暂无数据